Skip to search formSkip to main contentSkip to account menu

clopidogrel

Known as: Clopidogrelum, clopidogrel [Chemical/Ingredient], methyl 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno(3,2-c)pyridin-5-yl)acetate 
a kind of anti-clotting drug
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Highly Cited
2009
Highly Cited
2009
BACKGROUND Ticagrelor is an oral, reversible, direct-acting inhibitor of the adenosine diphosphate receptor P2Y12 that has a more… 
Highly Cited
2009
Highly Cited
2009
BACKGROUND Clopidogrel requires transformation into an active metabolite by cytochrome P-450 (CYP) enzymes for its antiplatelet… 
Highly Cited
2009
Highly Cited
2009
BACKGROUND Pharmacogenetic determinants of the response of patients to clopidogrel contribute to variability in the biologic… 
Highly Cited
2009
Highly Cited
2009
BACKGROUND Vitamin K antagonists reduce the risk of stroke in patients with atrial fibrillation but are considered unsuitable in… 
Highly Cited
2007
Highly Cited
2007
BACKGROUND Dual-antiplatelet therapy with aspirin and a thienopyridine is a cornerstone of treatment to prevent thrombotic… 
Highly Cited
2006
Highly Cited
2006
BACKGROUND Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been studied in a broad population of… 
Highly Cited
2001
Highly Cited
2001
BACKGROUND Despite current treatments, patients who have acute coronary syndromes without ST-segment elevation have high rates of… 
Highly Cited
2001
Highly Cited
2001
A BSTRACT Background Despite current treatments, patients who have acute coronary syndromes without ST-segment elevation have… 
Highly Cited
1996
Highly Cited
1996
Background Many clinical trials have evaluated the benefit of long-term use of antiplatelet drugs in reducing the risk of…